文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

新型冠状病毒肺炎患者口腔黏膜病变:系统评价。

COVID-19-related oral mucosa lesions among confirmed SARS-CoV-2 patients: a systematic review.

机构信息

School of Medicine, Technical University of Munich, Munchen, Germany.

Department of Dermatology, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Turkey.

出版信息

Int J Dermatol. 2022 Jan;61(1):20-32. doi: 10.1111/ijd.15889. Epub 2021 Sep 22.


DOI:10.1111/ijd.15889
PMID:34549816
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8652904/
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible for coronavirus disease 2019 (COVID-19), which manifests as a flu-like respiratory infection affecting multiple organ systems, including the gastrointestinal system, central nervous system, cardiovascular system, skin, and mucosa. In this review, we investigated the literature on specific manifestations of COVID-19 in the oral mucosa. An online literature search in PubMed, Scopus, Google Scholar, and Medline was conducted to retrieve relevant studies on confirmed COVID-19 patients with oral mucosa findings published between December 31, 2019, and April 07, 2021. After an independent review by two authors, 39 articles considering 59 laboratory-confirmed cases of SARS-CoV-2 infection were included in the final analysis. The most common finding, reported in 29 patients (43.9%), was Kawasaki-like syndrome. In addition, oral ulcers including aphthous, hemorrhagic, and necrotic ulcers were reported in 24 patients (36.3%). Other lesions reported included pustules, macules, bullae, maculopapular enanthema, and erythema multiforme-like lesions. Concomitant skin lesions were present in 60.6% of patients. Fever was reported in 86.2% of patients. Forty-eight patients (76.1%) were hospitalized. Loss of taste and smell was present in 30.8% of the patients. A comprehensive understanding of the dermatologic manifestations of COVID-19 can improve and facilitate patient management and referrals.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)是导致 2019 年冠状病毒病(COVID-19)的病毒,其表现为类似于流感的呼吸道感染,影响多个器官系统,包括胃肠道、中枢神经系统、心血管系统、皮肤和黏膜。在这篇综述中,我们调查了 COVID-19 口腔黏膜具体表现的文献。在 PubMed、Scopus、Google Scholar 和 Medline 上进行了在线文献检索,以检索 2019 年 12 月 31 日至 2021 年 4 月 7 日期间发表的关于口腔黏膜有发现的确诊 COVID-19 患者的相关研究。经过两位作者的独立审查,最终分析纳入了 39 篇考虑了 59 例 SARS-CoV-2 感染的实验室确诊病例的文章。最常见的发现是 29 例(43.9%)患者报告的川崎病样综合征。此外,24 例(36.3%)患者报告有口腔溃疡,包括阿弗他溃疡、出血性溃疡和坏死性溃疡。其他报告的病变包括脓疱、斑疹、水疱、斑丘疹口腔黏膜炎和多形红斑样病变。60.6%的患者伴有皮肤病变。86.2%的患者有发热。48 例(76.1%)患者住院。30.8%的患者味觉和嗅觉丧失。全面了解 COVID-19 的皮肤表现可以改善和促进患者的管理和转诊。

相似文献

[1]
COVID-19-related oral mucosa lesions among confirmed SARS-CoV-2 patients: a systematic review.

Int J Dermatol. 2022-1

[2]
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Cochrane Database Syst Rev. 2022-5-20

[3]
Measures implemented in the school setting to contain the COVID-19 pandemic.

Cochrane Database Syst Rev. 2022-1-17

[4]
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.

Cochrane Database Syst Rev. 2022-7-22

[5]
Antibody tests for identification of current and past infection with SARS-CoV-2.

Cochrane Database Syst Rev. 2022-11-17

[6]
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.

Cochrane Database Syst Rev. 2022-9-20

[7]
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.

Cochrane Database Syst Rev. 2021-9-2

[8]
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.

Cochrane Database Syst Rev. 2022-5-6

[9]
Prevalence of oral manifestations in COVID-19: A systematic review.

Rev Med Virol. 2022-11

[10]
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.

Cochrane Database Syst Rev. 2022-6-17

引用本文的文献

[1]
Frequency of Oral Lesions, Olfactory, and Gustatory Disorders and Xerostomia in Patients with COVID-19.

Dent J (Basel). 2024-6-11

[2]
Oral Mucosal Manifestations Associated with PCR Positivity in Patients with COVID-19.

Dermatol Pract Concept. 2024-1-1

[3]
Increased prevalence of erythema multiforme in patients with COVID-19 infection or vaccination.

Sci Rep. 2024-2-2

[4]
A reflection on COVID-19 and oral mucosal lesion: a systematic review.

Front Oral Health. 2023-12-18

[5]
Awareness of undergraduate dental students, interns, and freshly graduated dentists about oral manifestation associated with COVID-19.

BMC Oral Health. 2023-12-9

[6]
Prevalence of oral complications in the course of severe SARS-CoV-2 infection under mechanical non-invasive ventilation.

Eur J Med Res. 2023-8-22

[7]
The Oral Lesion in the COVID-19 Patient: Is It True Oral Manifestation or Not?

Infect Drug Resist. 2023-7-4

[8]
COVID-19 and Related Vaccinations in Children: Pathogenic Aspects of Oral Lesions.

Children (Basel). 2023-4-29

[9]
The oral manifestations and related mechanisms of COVID-19 caused by SARS-CoV-2 infection.

Front Cell Neurosci. 2023-1-4

[10]
Associations between Emotional Distress, Sleep Changes, Decreased Tooth Brushing Frequency, Self-Reported Oral Ulcers and SARS-Cov-2 Infection during the First Wave of the COVID-19 Pandemic: A Global Survey.

Int J Environ Res Public Health. 2022-9-14

本文引用的文献

[1]
Reactive Infectious Mucocutaneous Eruption Associated With SARS-CoV-2 Infection.

JAMA Dermatol. 2021-5-1

[2]
SARS-CoV-2 infection of the oral cavity and saliva.

Nat Med. 2021-5

[3]
SARS-CoV-2 infection triggering recurrence of Kawasaki disease in a 10-year-old child.

BMJ Case Rep. 2021-3-24

[4]
Tongue and floor of mouth swelling: a potential rare manifestation of COVID-19.

Br J Oral Maxillofac Surg. 2021-5

[5]
Persistent lesions in oral cavity after SARS-CoV-2 infection.

Oral Dis. 2022-11

[6]
The clinical spectrum of COVID-19-associated cutaneous manifestations: An Italian multicenter study of 200 adult patients.

J Am Acad Dermatol. 2021-5

[7]
Oral vesiculobullous lesions as an early sign of COVID-19: immunohistochemical detection of SARS-CoV-2 spike protein.

Br J Dermatol. 2021-1

[8]
Discovering Associations: Kawasaki Disease and COVID-19.

Case Rep Pediatr. 2020-9-28

[9]
Oral candidiasis in non-severe COVID-19 patients: call for antibiotic stewardship.

Oral Surg. 2022-8

[10]
A challenging case of multisystem inflammatory syndrome in children related to coronavirus Disease-19 hospitalized under adult medical service.

IDCases. 2020

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索